2′-Hydroxyflavanone: A Bioactive Compound That Protects against Cancers
Source abstract
Abstract
Cancer is defined as a multifactorial disease because it exhibits the continuous proliferation of malignant cells. It is one of the principal causes of death worldwide, with breast cancer occurrence being the highest among women and lung cancer being the highest among men. Hydroxyflavanones come under the category of flavonones and are further classified as 2′-hydroxyflavanone, 4′-hydroxyflavanone, 6-hydroxyflavanone, 7-hydroxyflavanone, etc. Flavonoids constitute approximately 60% of the total dietary polyphenols. Dietary components such as vegetables, fruits, cereals, soybeans, and tea are the chief sources of flavonoids, while citrus fruits contain a high amount of hydroxyflavanones. 2′-Hydroxyflavanone is known to have anti-inflammatory, antimutagenic, and anticancer activities. Hence, it is being investigated as a treatment for various diseases, especially cancer. 2′-Hydroxyflavanone can act as a chemotherapeutic agent in cancer. It restricts the signal transducer and activator of the transcription 3 pathway (STAT3) in some forms of cancer.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Phytochemicals and Antioxidant Activities · Chromatography in Natural Products · Natural Antidiabetic Agents Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
School of Bioengineering and Biosciences, Lovely Professional University, Phagwara 144411, India
Indian Scientific Education and Technology Foundation, Lucknow 226002, India
Faculty of Biotechnology, University of Agricultural Sciences and Veterinary Medicine, 011464 Bucharest, Romania
References (64)
Show source-provided references
1. Cancer prevention from the perspective of global cancer burden patterns10.21037/jtd.2017.02.75 ↗
2. What is the role of immunotherapy in breast cancer?10.21037/cco.2018.04.01 ↗
3. Dietary phytochemicals in cancer prevention and therapy: A complementary approach with promising perspectives10.1111/nure.12051 ↗
4. Plant polyphenols as dietary antioxidants in human health and disease10.4161/oxim.2.5.9498 ↗
5. Yousuf, S., Shabir, S., and Singh, M.P. (2022). Protection against drug-induced liver injuries through nutraceuticals via amelioration of Nrf-2 signaling. J. Am. Nutr. Assoc.10.1080/27697061.2022.2089403 ↗
6. Health-Promoting Components of Fruits and Vegetables in the Diet10.3945/an.112.003517 ↗
7. A Comparative account on Antioxidant Activities, Total Phenolic and Flavonoid Contents of Punicagranatum, Caricapapaya, Foeniculum vugare, Trigonellafoenum-graecum and Urtica dioica: An In Vitro Evaluation10.52711/0974-360X.2022.00197 ↗
8. Pharmacological treatment of dementia: A scoping review of systematic reviews10.1159/000353892 ↗
9. Flavonoids: An overview10.1017/jns.2016.41 ↗
10. Polyphenols: Food sources and bioavailability10.1093/ajcn/79.5.727 ↗
11. Cha, S.J., Do, H.A., Choi, H.J., Lee, M., and Kim, K. (2019). The Drosophila Model: Exploring Novel Therapeutic Compounds against Neurodegenerative Diseases. Antioxidants, 6.10.3390/antiox8120623 ↗
12. Ameliorative role of nutraceuticals on neurodegenerative diseases using the Drosophila melanogaster as a discovery model to define bioefficacy
13. Anticancer activity of 2′-hydroxyflavanone towards lung cancer10.18632/oncotarget.26329 ↗
14. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries10.3322/caac.21660 ↗
15. Proteomics and the search for biomarkers for renal cancer10.1016/j.clinbiochem.2012.11.029 ↗
16. 2′-Hydroxyflavanone inhibits proliferation, and tumor vascularization and promotes normal differentiation in VHL-mutant renal cell carcinoma10.1093/carcin/bgr021 ↗
17. Bose, C., Singh, S.P., Igid, H., Green, W.C., Singhal, S.S., Lee, J., Palade, P.T., Rajan, A., Ball, S., and Tonk, V. (2019). Topical 2′-Hydroxyflavanone for Cutaneous Melanoma. Cancers, 11.10.3390/cancers11101556 ↗
18. 2′- Hydroxyflavanone: A novel strategy for targeting breast cancer10.18632/oncotarget.20499 ↗
19. 2′-Hydroxyflavanone: A promising molecule for kidney cancer prevention10.1016/j.bcp.2015.04.022 ↗
20. Risk Factors and Preventions of Breast Cancer10.7150/ijbs.21635 ↗
21. 2′-Hydroxyflavanone effectively targets RLIP76-mediated drug transport and regulate critical signaling networks in breast cancer10.18632/oncotarget.24720 ↗
22. Hydroxyflavanone inhibits gastric carcinoma MGC-803 cell proliferation
23. Tolomeo, M., and Cascio, A. (2021). The Multifaced Role of STAT3 in Cancer and Its Implication for Anticancer Therapy. Int. J. Mol. Sci., 22.10.3390/ijms22020603 ↗
24. Role of STAT3 signaling pathway in breast cancer10.1186/s12964-020-0527-z ↗
25. Kamran, M.Z., Patil, P., and Gude, R.P. (2013). Role of STAT3 in Cancer Metastasis and Translational Advances. BioMed Res. Int., 421821.10.1155/2013/421821 ↗
26. RLIP inhibition suppresses breast-to-lung metastasis10.1016/j.canlet.2019.01.023 ↗
27. The epidemiology of lung cancer10.21037/tlcr.2018.05.06 ↗
28. Beyzadeoglu, M., Ozyigit, G., and Ebruli, C. (2022). Lung Cancer. Basic Radiation Oncology, Springer.10.1007/978-3-030-87308-0 ↗
29. Flavonone and 2′-OH flavonone inhibit metastasis of lung cancer cells via downregulation of proteinase activities and the MAPK pathway10.1016/j.cbi.2007.02.012 ↗
30. ERK/MAPK signaling pathway and tumorigenesis (Review)
31. Mitogen-activated protein kinase signaling pathway in oral cancer
32. Repression of cell proliferation and androgen receptor activity in prostate cancer cells by 2′-hydroxyflavanone
33. 2′-Hydroxyflavanone inhibits prostate tumor growth through inactivation of AKT/STAT3 signaling and induction of cell apoptosis10.3892/or.2014.3218 ↗
34. 2′-Hydroxyflavanone inhibits the progression of pancreatic cancer cells and sensitizes the chemosensitivity of EGFR inhibitors by repressing STAT3 signaling10.1016/j.canlet.2019.11.041 ↗
35. A new flavonoid derivative exerts antitumor effects against androgen-sensitive to cabazitaxel-resistant prostate cancer cells10.1002/pros.24106 ↗
36. 2′-Hydroxyflavanone inhibits epithelial-mesenchymal transition, and cell migration and invasion via suppression of the Wnt/β-catenin signaling pathway in prostate cancer
37. AKR1C3 as a potential target for the inhibitory effect of dietary flavonoids10.1016/j.cbi.2008.10.015 ↗
38. The epidemiology of osteosarcoma10.1007/978-1-4419-0284-9_1 ↗
39. 2′-hydroxyflavanone induces apoptosis of human osteosarcoma 143 B cells by activating the extrinsic TRAIL- and intrinsic mitochondria-mediated pathways10.1080/01635581.2014.894100 ↗
40. Ward, W.H., and Farma, J.M. (2017). Chapter 1 Epidemiology of Melanoma. Cutaneous Melanoma: Etiology and Therapy [Internet], Codon Publications.10.15586/codon.cutaneousmelanoma.2017 ↗
41. Roche, J. (2018). The Epithelial-to-Mesenchymal Transition in Cancer. Cancers, 10.10.3390/cancers10020052 ↗
42. EMT Factors and Metabolic Pathways in Cancer10.3389/fonc.2020.00499 ↗
43. Epithelial-Mesenchymal Transition in Cancer: A Historical Overview10.1016/j.tranon.2020.100773 ↗
44. Waldum, H.L., and Fossmark, R. (2018). Types of Gastric Carcinomas. Int. J. Mol. Sci., 19.10.3390/ijms19124109 ↗
45. Epidemiology of gastric cancer: Global trends, risk factors, and prevention
46. Inhibitory effect of 2′-hydroxyflavanone on proliferation, invasion, and migration of bladder cancer cells in vitro by blocking AKT/STAT3 signaling pathway
47. Colorectal Cancer10.1038/nrdp.2015.65 ↗
48. 2′-Hydroxyflavanone induces apoptosis through Egr-1 involving expression of Bax, p21, and NAG-1 in colon cancer cells10.1002/mnfr.201100651 ↗
49. Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors10.14740/wjon1166 ↗
50. Effects of flavonoids with different structures on the proliferation of leukemia cell line HL-60
51. Gervazoni, L.F.O., Ozório, G.G., and Amaral, E.E.A. (2018). 2′-Hydroxyflavanone activity in vitro and in vivo against wild-type and antimony-resistant Leishmania amazonensis. PLoS Negl. Trop. Dis., 12.10.1371/journal.pntd.0006930 ↗
52. 2′-Hydroxyflavanone ameliorates mesenteric angiogenesis and portal-systemic collaterals in rats with liver fibrosis10.1111/jgh.13197 ↗
53. 2′-Hydroxyflavanone prevents LPS-induced inflammatory response and cytotoxicity in murine macrophages10.1016/j.tiv.2020.104966 ↗
54. Screening of flavonoids as candidate antibiotics against Enterococcus faecalis10.1021/np800698d ↗
55. Biflavans, Flavonoids, and a Dihydrochalcone from the Stem Wood of Muntingia calabura and Their Inhibitory Activities on Neutrophil Pro-Inflammatory Responses10.3390/molecules191220521 ↗
56. Potentiality of standardized extract and isolated flavonoids from Zuccagnia punctata for the treatment of respiratory infections by Streptococcus pneumoniae: In vitro and in vivo studies10.1016/j.jep.2012.01.019 ↗
57. Effects of Zuccagnia punctata extracts and their flavonoids on the function and expression of ABCB1/P-glycoprotein multidrug transporter10.1016/j.jep.2012.10.012 ↗
58. Synthetic flavonones augment the anticancer effect of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)10.3390/molecules171011693 ↗
59. Effect of different flavonoids on collagen synthesis in human fibroblasts10.1007/s11130-006-0006-8 ↗
60. Actions of some flavonoids on specific and nonspecific immune mechanisms10.1016/S0944-7113(96)80035-3 ↗
61. 4′-Hydroxyflavanone suppresses activation of sterol regulatory element-binding proteins and de novo lipid synthesis10.1016/j.febslet.2012.04.060 ↗
62. Shabir, S., Yousuf, S., Singh, S.K., Vamanu, E., and Singh, M.P. (2022). Ethnopharmacological effects of Urtica dioica, Matricaria chamomilla, and Murraya koinegii on rotenone exposed D. melanogaster: An attenuation of cellular, biochemical and organismal markers. Antioxidants, 11.10.3390/antiox11081623 ↗
63. In vivo and in vitro antioxidant activity of Cnicus benedictus
64. The subgroup of 2′ -hydroxy-flavonoids: Molecular diversity, mechanism of action, and anticancer properties10.1016/j.bmc.2021.116001 ↗